Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ubiquitin-like ligase-substrate adaptor activity	PRAMEF9 PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	1.54e-06	82	48	5	GO:1990756
GeneOntologyMolecularFunction	enzyme-substrate adaptor activity	PRAMEF9 PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	3.19e-06	95	48	5	GO:0140767
GeneOntologyMolecularFunction	nuclear retinoic acid receptor binding	PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	9.16e-06	55	48	4	GO:0042974
GeneOntologyMolecularFunction	nuclear receptor binding	PRAMEF15 PRAMEF4 GRM1 PRAMEF27 PRAMEF11	8.43e-05	187	48	5	GO:0016922
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	PRAMEF15 PSMD10 PRAMEF4 GRM1 PRAMEF27 PRAMEF11	4.68e-04	417	48	6	GO:0061629
GeneOntologyMolecularFunction	proteasome binding	PSME4 SACS	1.05e-03	20	48	2	GO:0070628
GeneOntologyMolecularFunction	G protein-coupled receptor activity	FZD6 OR2W3 OR10J5 OR4C11 GPR149 OR5C1 GRM1 OR13J1	1.12e-03	884	48	8	GO:0004930
GeneOntologyMolecularFunction	transcription factor binding	PRAMEF15 PSMD10 PRAMEF4 GRM1 TERT PRAMEF27 PRAMEF11	2.02e-03	753	48	7	GO:0008134
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	PRAMEF15 PSMD10 PRAMEF4 GRM1 PRAMEF27 PRAMEF11	2.59e-03	582	48	6	GO:0140297
GeneOntologyCellularComponent	Cul2-RING ubiquitin ligase complex	PRAMEF9 PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	8.17e-08	47	49	5	GO:0031462
GeneOntologyCellularComponent	intracellular protein-containing complex	PRAMEF9 PSME4 POLA1 PRAMEF15 PSMD10 PRAMEF4 TRRAP TERT PRAMEF27 PRAMEF11	7.09e-05	972	49	10	GO:0140535
GeneOntologyCellularComponent	cullin-RING ubiquitin ligase complex	PRAMEF9 PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	1.36e-04	212	49	5	GO:0031461
GeneOntologyCellularComponent	transferase complex	PHKA1 PRAMEF9 POLA1 PRAMEF15 PRAMEF4 TRRAP TERT PRAMEF27 PRAMEF11	3.51e-04	963	49	9	GO:1990234
HumanPheno	Fundus hemorrhage	ESAM TERT CFHR3	5.07e-05	30	13	3	HP:0031803
HumanPheno	Retinal hemorrhage	ESAM TERT CFHR3	5.07e-05	30	13	3	HP:0000573
MousePheno	abnormal spermatogonia proliferation	PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	2.50e-06	47	29	4	MP:0002685
MousePheno	abnormal male germ cell apoptosis	PSME4 PRAMEF15 PRAMEF4 TERT PRAMEF27 PRAMEF11	7.45e-06	236	29	6	MP:0008280
MousePheno	abnormal male germ cell physiology	PSME4 PRAMEF15 PRAMEF4 TERT PRAMEF27 PRAMEF11	9.02e-06	244	29	6	MP:0020362
MousePheno	abnormal germ cell physiology	PSME4 PRAMEF15 PRAMEF4 TERT PRAMEF27 PRAMEF11	1.51e-05	267	29	6	MP:0020363
MousePheno	increased male germ cell apoptosis	PSME4 PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	3.91e-05	189	29	5	MP:0014052
MousePheno	abnormal seminal vesicle morphology	RANBP17 PRAMEF15 PRAMEF4 CD83 CCDC157 PRAMEF11	4.11e-05	319	29	6	MP:0002059
MousePheno	abnormal male accessory sex gland morphology	RANBP17 PRAMEF15 PRAMEF4 CD83 CCDC157 PRAMEF11	7.80e-05	358	29	6	MP:0013330
MousePheno	abnormal jejunum morphology	PRAMEF15 PRAMEF4 PRAMEF11	8.12e-05	41	29	3	MP:0004002
MousePheno	abnormal Purkinje cell dendrite morphology	ANKFY1 SACS DNM1	2.29e-04	58	29	3	MP:0008572
MousePheno	abnormal duodenum morphology	PRAMEF15 PRAMEF4 PRAMEF11	3.07e-04	64	29	3	MP:0003271
MousePheno	cataract	STIM2 PRAMEF15 PRAMEF4 PRAMEF27 ACOX3 PRAMEF11	4.63e-04	497	29	6	MP:0001304
Domain	PRAME_family	PRAMEF25 PRAMEF15 PRAMEF4 PRAMEF27	1.21e-07	19	46	4	IPR026271
Domain	-	RANBP17 PSME4 HEATR1 TRRAP	2.14e-03	222	46	4	1.25.10.10
Domain	Olfact_rcpt	OR2W3 OR10J5 OR4C11 OR5C1 OR13J1	2.71e-03	393	46	5	IPR000725
Domain	ARM-like	RANBP17 PSME4 HEATR1 TRRAP	4.33e-03	270	46	4	IPR011989
Domain	GPCR_Rhodpsn_7TM	OR2W3 OR10J5 OR4C11 GPR149 OR5C1 OR13J1	5.76e-03	670	46	6	IPR017452
Domain	7tm_1	OR2W3 OR10J5 OR4C11 GPR149 OR5C1 OR13J1	6.05e-03	677	46	6	PF00001
Domain	G_PROTEIN_RECEP_F1_1	OR2W3 OR10J5 OR4C11 GPR149 OR5C1 OR13J1	6.40e-03	685	46	6	PS00237
Domain	G_PROTEIN_RECEP_F1_2	OR2W3 OR10J5 OR4C11 GPR149 OR5C1 OR13J1	6.67e-03	691	46	6	PS50262
Domain	GPCR_Rhodpsn	OR2W3 OR10J5 OR4C11 GPR149 OR5C1 OR13J1	6.71e-03	692	46	6	IPR000276
Domain	-	PRAMEF25 PRAMEF15 PRAMEF4 PRAMEF27	7.92e-03	321	46	4	3.80.10.10
Domain	L_dom-like	PRAMEF25 PRAMEF15 PRAMEF4 PRAMEF27	8.53e-03	328	46	4	IPR032675
Domain	ARM-type_fold	RANBP17 PSME4 HEATR1 TRRAP	9.55e-03	339	46	4	IPR016024
Domain	HEAT_REPEAT	PSME4 HEATR1	1.29e-02	70	46	2	PS50077
Pathway	REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT	FZD6 PSME4 PSMD10 TRRAP TERT	3.55e-05	158	34	5	MM14791
Pathway	REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT	FZD6 PSME4 PSMD10 TRRAP TERT	2.22e-04	233	34	5	M27099
Pathway	REACTOME_SIGNALING_BY_WNT	FZD6 PSME4 PSMD10 TRRAP TERT	2.50e-04	239	34	5	MM14756
Pubmed	Preferentially Expressed Antigen in Melanoma (PRAME) and the PRAME Family of Leucine-Rich Repeat Proteins.	PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	1.66e-08	20	49	4	26694250
Pubmed	Sertoli cell-only phenotype and scRNA-seq define PRAMEF12 as a factor essential for spermatogenesis in mice.	PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	2.50e-08	22	49	4	31729367
Pubmed	MAGE-B4, a binding partner of PRAMEF12, is dispensable for spermatogenesis and male fertility in mice.	PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	4.30e-08	25	49	4	37451217
Pubmed	Differences in gene expression between mouse and human for dynamically regulated genes in early embryo.	PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	6.94e-08	28	49	4	25089626
Pubmed	Retinoic acid receptors are required for skeletal growth, matrix homeostasis and growth plate function in postnatal mouse.	PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	1.76e-07	35	49	4	19389355
Pubmed	Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse.	PRAMEF15 PRAMEF4 PRAMEF11	1.76e-06	17	49	3	23565261
Pubmed	Mouse Pramel1 regulates spermatogonial development by inhibiting retinoic acid signaling during spermatogenesis.	PRAMEF15 PRAMEF4 PRAMEF11	1.76e-06	17	49	3	37781892
Pubmed	Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes.	PRAMEF15 PRAMEF4 PRAMEF11	2.11e-06	18	49	3	29731491
Pubmed	The promoter of the oocyte-specific gene, Oog1, functions in both male and female meiotic germ cells in transgenic mice.	PRAMEF15 PRAMEF4 PRAMEF11	2.11e-06	18	49	3	23894331
Pubmed	Identification of a new expanding family of genes characterized by atypical LRR domains. Localization of a cluster preferentially expressed in oocyte.	PRAMEF15 PRAMEF4 PRAMEF11	2.11e-06	18	49	3	14675769
Pubmed	Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos.	PRAMEF15 PRAMEF4 PRAMEF11	2.11e-06	18	49	3	12890732
Pubmed	Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation.	PRAMEF15 PRAMEF4 PRAMEF11	2.11e-06	18	49	3	39181896
Pubmed	Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways.	PRAMEF15 PRAMEF4 PRAMEF11	2.51e-06	19	49	3	28604677
Pubmed	Oog1, an oocyte-specific protein, interacts with Ras and Ras-signaling proteins during early embryogenesis.	PRAMEF15 PRAMEF4 PRAMEF11	2.95e-06	20	49	3	16580637
Pubmed	Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells.	PRAMEF15 PRAMEF4 PRAMEF11	2.95e-06	20	49	3	21425410
Pubmed	Oogenesis specific genes (Nobox, Oct4, Bmp15, Gdf9, Oogenesin1 and Oogenesin2) are differentially expressed during natural and gonadotropin-induced mouse follicular development.	PRAMEF15 PRAMEF4 PRAMEF11	4.56e-06	23	49	3	19480014
Pubmed	KIFC1 regulated by miR-532-3p promotes epithelial-to-mesenchymal transition and metastasis of hepatocellular carcinoma via gankyrin/AKT signaling.	PSMD10 KIFC1	5.83e-06	3	49	2	30115976
Pubmed	Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei.	PRAMEF15 PRAMEF4 PRAMEF11	5.91e-06	25	49	3	12620990
Pubmed	Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3.	PRAMEF15 PRAMEF4 PRAMEF11	6.68e-06	26	49	3	18500982
Pubmed	Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice.	PRAMEF15 PRAMEF4 PRAMEF11	1.04e-05	30	49	3	38786026
Pubmed	TRRAP-dependent and TRRAP-independent transcriptional activation by Myc family oncoproteins.	TRRAP TERT	1.16e-05	4	49	2	12077335
Pubmed	LSM14B is essential for oocyte meiotic maturation by regulating maternal mRNA storage and clearance.	PRAMEF15 PRAMEF4 PRAMEF11	1.27e-05	32	49	3	37889087
Pubmed	Multiple Grb2-protein complexes in human cancer cells.	PSMD10 DNM1	1.94e-05	5	49	2	9009162
Pubmed	Mbd3, a component of the NuRD co-repressor complex, is required for development of pluripotent cells.	PRAMEF15 PRAMEF4 PRAMEF11	3.82e-05	46	49	3	17287250
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	FZD6 PHKA1 POLA1 PRAMEF15 PRAMEF4 PRAMEF11 IGSF23	4.22e-05	674	49	7	37196079
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	PRAMEF15 PRAMEF4 PRAMEF11	4.92e-05	50	49	3	31806660
Pubmed	ZAR1 and ZAR2 are required for oocyte meiotic maturation by regulating the maternal transcriptome and mRNA translational activation.	PRAMEF15 PRAMEF4 PRAMEF11	7.68e-05	58	49	3	31598710
Pubmed	An abundance of X-linked genes expressed in spermatogonia.	PRAMEF15 PRAMEF4 PRAMEF11	8.08e-05	59	49	3	11279525
Pubmed	Different evolutionary processes shaped the mouse and human olfactory receptor gene families.	OR2W3 OR10J5 OR4C11 OR5C1 OR13J1	1.16e-04	340	49	5	11875048
Pubmed	The olfactory receptor gene superfamily of the mouse.	OR2W3 OR10J5 OR4C11 OR5C1 OR13J1	1.16e-04	340	49	5	11802173
Pubmed	A unified nomenclature for vertebrate olfactory receptors.	OR2W3 OR10J5 OR4C11 OR5C1 OR13J1	1.21e-04	343	49	5	32295537
Pubmed	Odorant receptor expressed sequence tags demonstrate olfactory expression of over 400 genes, extensive alternate splicing and unequal expression levels.	OR2W3 OR10J5 OR4C11 OR5C1 OR13J1	1.26e-04	346	49	5	14611657
Pubmed	The contribution of rare and common variants in 30 genes to risk nicotine dependence.	NRXN3 DNM1	1.75e-04	14	49	2	25450229
Pubmed	The CRL4DCAF6 E3 ligase ubiquitinates CtBP1/2 to induce apoptotic signalling and promote intervertebral disc degeneration.	ANKFY1 LAMP1 GRM1 DNM1	1.80e-04	199	49	4	36688959
Pubmed	Deterministic and stochastic allele specific gene expression in single mouse blastomeres.	FZD6 PRAMEF15 PRAMEF4 TERT PRAMEF11	3.23e-04	424	49	5	21731673
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	PSME4 PRAMEF15 PSMD10 HEATR1 PRAMEF4 ANKRD50 PRAMEF11	7.68e-04	1084	49	7	11544199
Pubmed	Cell Surface Proteomic Map of HIV Infection Reveals Antagonism of Amino Acid Metabolism by Vpu and Nef.	FZD6 NRXN3 CD83	8.67e-04	132	49	3	26439863
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	ANKFY1 PSME4 ARHGEF10 POLA1 LAMP1 PSMD10 ZW10 DNM1	9.00e-04	1455	49	8	22863883
Pubmed	HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages.	POLA1 KIFC1	9.39e-04	32	49	2	27114546
Pubmed	Gene-smoking interactions identify several novel blood pressure loci in the Framingham Heart Study.	NRXN3 SACS	9.39e-04	32	49	2	25189868
Pubmed	The human olfactory receptor gene family.	OR2W3 OR10J5 OR4C11 OR5C1 OR13J1	9.70e-04	541	49	5	14983052
Pubmed	The CARM1-p300-c-Myc-Max (CPCM) transcriptional complex regulates the expression of CUL4A/4B and affects the stability of CRL4 E3 ligases in colorectal cancer.	TRRAP TERT	9.98e-04	33	49	2	32140074
Pubmed	Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.	PSME4 PRAMEF15 PRAMEF4 DNM1 PRAMEF11	1.17e-03	564	49	5	21565611
Pubmed	An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein.	PSME4 PSMD10	1.25e-03	37	49	2	9811770
Pubmed	Hypermutation of HIV-1 DNA in the absence of the Vif protein.	PSME4 PSMD10	1.25e-03	37	49	2	12750511
Pubmed	Death by deamination: a novel host restriction system for HIV-1.	PSME4 PSMD10	1.25e-03	37	49	2	12914693
Pubmed	Good to CU.	PSME4 PSMD10	1.25e-03	37	49	2	12840737
Pubmed	Comprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virions.	PSME4 PSMD10	1.25e-03	37	49	2	12719574
Pubmed	Evidence for a newly discovered cellular anti-HIV-1 phenotype.	PSME4 PSMD10	1.25e-03	37	49	2	9846577
Pubmed	DNA deamination: not just a trigger for antibody diversification but also a mechanism for defense against retroviruses.	PSME4 PSMD10	1.25e-03	37	49	2	12830140
Pubmed	The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.	PSME4 PSMD10	1.32e-03	38	49	2	12808465
Pubmed	Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.	PSME4 PSMD10	1.32e-03	38	49	2	12808466
Pubmed	Virology. Weapons of mutational destruction.	PSME4 PSMD10	1.32e-03	38	49	2	12920286
Pubmed	HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability.	PSME4 PSMD10	1.32e-03	38	49	2	14527406
Pubmed	Degradation of HIV-1 integrase by the N-end rule pathway.	PSME4 PSMD10	1.32e-03	38	49	2	10893419
Pubmed	The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity.	PSME4 PSMD10	1.32e-03	38	49	2	14557625
Pubmed	DNA deamination mediates innate immunity to retroviral infection.	PSME4 PSMD10	1.32e-03	38	49	2	12809610
Pubmed	The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity.	PSME4 PSMD10	1.32e-03	38	49	2	12970355
Pubmed	The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G.	PSME4 PSMD10	1.32e-03	38	49	2	14614829
Pubmed	HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.	PSME4 PSMD10	1.39e-03	39	49	2	14528301
Interaction	PRAMEF4 interactions	PRAMEF9 PRAMEF4	1.53e-05	3	46	2	int:PRAMEF4
Cytoband	1p36.21	PRAMEF25 PRAMEF9 PRAMEF15 PRAMEF4 PRAMEF11	7.53e-09	63	49	5	1p36.21
Cytoband	Ensembl 112 genes in cytogenetic band chr1p36	PRAMEF25 PRAMEF9 PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	8.47e-05	681	49	6	chr1p36
GeneFamily	PRAME family	PRAMEF25 PRAMEF9 PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	7.46e-12	24	38	6	686
Coexpression	INGRAM_SHH_TARGETS_UP	ARHGEF10 POLA1 PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	3.54e-07	156	47	6	MM550
Coexpression	KOHOUTEK_CCNT2_TARGETS	PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	1.36e-05	81	47	4	MM938
Coexpression	MORI_SMALL_PRE_BII_LYMPHOCYTE_UP	PSME4 PRAMEF15 PRAMEF4 PRAMEF11	2.90e-05	98	47	4	MM592
Coexpression	KINNEY_DNMT1_METHYLATION_TARGETS	PRAMEF15 PRAMEF4 PRAMEF11	3.11e-05	34	47	3	MM955
ToppCell	TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Monophasic_Synovial_Sarcoma-5\|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9	PRAMEF9 PRAMEF15 PRAMEF4 PRAMEF11	3.37e-06	93	49	4	3e05ea0f8f4a7cdb78a596f47d563dc3c94d4d8e
Disease	Charlevoix-Saguenay spastic ataxia (implicated_via_orthology)	ANKFY1 SACS	1.79e-06	2	40	2	DOID:0050946 (implicated_via_orthology)
Disease	cerebral amyloid deposition measurement	NRXN3 HSD17B6 GRM1	2.93e-04	95	40	3	EFO_0007707
Disease	Hepatitis	ANKRD50 WDR72	4.07e-04	22	40	2	HP_0012115
Disease	creatinine measurement, chronic kidney disease	RSBN1L WDR72	1.04e-03	35	40	2	EFO_0003884, EFO_0004518
Disease	lobe attachment	SACS ANKRD50 GRM1	2.78e-03	207	40	3	EFO_0007667
Disease	proliferative diabetic retinopathy	NRXN3 WDR72	3.12e-03	61	40	2	EFO_0009322
Disease	obstructive sleep apnea	NRXN3 HSD17B6	3.64e-03	66	40	2	EFO_0003918
Disease	opioid dependence	NRXN3 ANKRD50 WDR72	4.06e-03	237	40	3	EFO_0005611

Protein segments in the cluster

Peptide	Gene	Start	Entry
MSLACTSQSLYAGLV	ARHGEF10	1026	O15013
LIQCLGMYDSSLAAK	ACOX3	106	O15254
LAMSYTCQAKNLTPL	ANKRD50	436	Q9ULJ7
LLLQSCMSYLENLGS	CCDC157	86	Q569K6
SKMVCTYGNQILSLG	RANBP17	801	Q9H2T7
MSRGLQLLLLSCAYS	CD83	1	Q01151
TVLLLAYMKGNANLC	ANKFY1	1046	Q9P2R3
LLANLYSCGDQNTLM	DNM1	701	Q05193
HIYSSLGCNNRMKLS	PHKA1	481	P46020
SANVYLESKGMSLCQ	GPR137C	231	Q8N3F9
TYLLQNSLGGSAKML	KIFC1	621	Q9BW19
LLYNLNGCDKTISYM	OR2W3	81	Q7Z3T1
QSLMFNGLLYIDLCK	NRXN3	836	Q9Y4C0
CLQKLYMNSVSFLEG	PRAMEF15	271	P0DUQ1
CSAMYLVTLLGNTAI	OR13J1	31	Q8NGT2
YMINLLLVSNSGAIC	OR4C11	191	Q6IEV9
YTTAMSQRLCLALLG	OR5C1	136	Q8NGR4
QKALKLTANSMYGCL	POLA1	946	P09884
LGATNLTMYSKISNC	ETAA1	731	Q9NY74
MYLCQGLSSNLKATL	GPR149	111	Q86SP6
LLAKGSCAYSDLQSM	NEU2	326	Q9Y3R4
GSQNKACTVLFMLLY	FZD6	276	O60353
MCKLGYNANTSILSF	CFHR3	301	Q02985
LGTYMCIATNSKKQL	IGSF23	106	A1L1A6
FSLLQLIANDCYKMG	TTC26	461	A0AVF1
LYNIMKEGLLNCSTN	HSD17B6	246	O14756
GMYQCLATNLLGTIL	CNTN6	96	Q9UQ52
LTNLSSSMAGVYVCK	ESAM	211	Q96AP7
CLLASMGLQLNLTYE	LAMP1	231	P11279
TQALYVGCAMLSSQK	HEATR1	891	Q9H583
SCYLQRLLVGLSSAM	GRM1	656	Q13255
TNLMLLPAKSLCYND	SACS	2456	Q9NZJ4
SNLMVCNLAYSGKLE	PSMD10	6	O75832
ILATNNCFLLTAMGY	OR10J5	106	Q8NHC4
MYSKSIQTICSGLLT	RSBN1L	271	Q6PCB5
CLQKLYMNSVSFLEG	PRAMEF25	271	A6NGN4
CLQKLYMNSVSFLEG	PRAMEF27	271	A3QJZ7
CTLSIANRLYGTKTM	SERPINB11	101	Q96P15
YRNLVSLGISSKCTM	ZNF525	41	Q8N782
CLQKLYMNSVSFLEG	PRAMEF4	271	O60810
YNGILEKSCSMNQLS	STIM2	671	Q9P246
CLQKLYMNSVSFLEG	PRAMEF9	271	P0DUQ2
LNMSSFYSCLRNGKN	WDR72	946	Q3MJ13
CLQKLYMNSVSFLEG	PRAMEF11	271	O60813
DAKLCLSLMSQGLLY	PSME4	1621	Q14997
LGNTCYMNAILQSLF	USP37	346	Q86T82
SMYSTLGRISKCNKL	ZFP69B	181	Q9UJL9
TLMILKSACSNNPSY	TRRAP	2271	Q9Y4A5
SLCYSILKAKNAGMS	TERT	1041	O14746
VNIYCKAMGTLLNTA	ZW10	646	O43264